In-111-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR

Míreanna comhchosúla

• 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
  de réir: Reilly, R, et al.
  Foilsithe / Cruthaithe: (2000)
• A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
  de réir: Reilly, R, et al.
  Foilsithe / Cruthaithe: (2000)
• Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.
  de réir: Chen, P, et al.
  Foilsithe / Cruthaithe: (2002)
• Amplified delivery of indium-111 to EGFR-positive human breast cancer cells.
  de réir: Wang, J, et al.
  Foilsithe / Cruthaithe: (2001)
• The anti-tumor effect of the auger electron-emitting radiopharmaceutical, In-111-hEGF against MDA-MB-468 human breast cancer xenografts is tumor-size dependent.
  de réir: Chen, P, et al.
  Foilsithe / Cruthaithe: (2001)